Systemic lupus erythematosus (SLE): Nursing

Last updated: April 13, 2022

Systemic lupus erythematosus (SLE): Nursing

Watch later

Watch later

Cholinomimetics: Direct agonists
Immunosuppressants for autoimmune diseases: Nursing pharmacology
Osteoporosis: Nursing
Osteomyelitis: Nursing
Paget disease of bone: Nursing
Cerebral palsy: Nursing
Down syndrome (Trisomy 21)
Encephalitis: Nursing
Headaches: Pathology review
Meningitis: Nursing process (ADPIE)
Seizure disorder: Nursing process (ADPIE)
Stroke: Nursing process (ADPIE)
Erysipelas and cellulitis: Nursing
Antibiotics - Penicillins: Nursing pharmacology
Antifungals - Topical: Nursing pharmacology
Cutaneous fungal infections: Nursing
Antibiotics - Cephalosporins: Nursing pharmacology
Antibiotics - Macrolides: Nursing pharmacology
Antivirals for influenza: Nursing pharmacology
Antivirals for herpesviruses: Nursing pharmacology
Antivirals for hepatitis B and C: Nursing pharmacology
Antibiotics - Fluoroquinolones: Nursing pharmacology
Antibiotics - Tetracyclines and glycylcyclines: Nursing pharmacology
Antidepressants - Tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs): Nursing pharmacology
Glaucoma: Nursing process (ADPIE)
Antidepressants - SSRIs and SNRIs: Nursing pharmacology
Gout: Nursing process (ADPIE)
Antiretrovirals for HIV/AIDS - CCR5 antagonists, fusion inhibitors, and attachment inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Integrase strand transfer inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - Protease inhibitors: Nursing pharmacology
Antiretrovirals for HIV/AIDS - NRTIs and NNRTIs: Nursing pharmacology
Cataracts: Nursing
Detached retina: Nursing
Macular degeneration: Nursing
Meniere disease: Nursing
Growth and development - Infant: Nursing
Otitis media: Nursing
Eye anesthetics: Nursing pharmacology
Mydriatics and cycloplegics: Nursing pharmacology
Ophthalmic anti-inflammatories and anti-infectives: Nursing pharmacology
Diabetes mellitus (DM): Nursing process (ADPIE)
Anatomy and physiology of the eye
Physical assessment - Eyes: Nursing
Conjunctivitis: Nursing process (ADPIE)
Eye conditions: Inflammation, infections and trauma: Pathology review
Anatomy of the eye
Pediatric psychosocial needs during illness and hospitalization: Nursing
Hearing impairment and otosclerosis: Nursing
Growth and development theories: Nursing
Growth and development - Preschool-age: Nursing
Growth and development - Toddler: Nursing
Growth and development - School-age: Nursing
Growth and development - Adolescent: Nursing
Antibiotics - Carbapenems and monobactams: Nursing pharmacology
Antibiotics - Trimethoprim and sulfonamides: Nursing pharmacology
Antibiotics - Beta lactam and beta lactamase inhibitor combinations: Nursing pharmacology
Antibiotics - Aminoglycosides: Nursing pharmacology
Medications for respiratory syncytial virus (RSV): Nursing pharmacology
Mycobacterium tuberculosis (Tuberculosis)
Hypersensitivity reactions - Type II: Nursing
Lyme disease: Nursing process (ADPIE)
Systemic lupus erythematosus (SLE): Nursing
Preoperative care: Nursing
Postoperative care: Nursing
Chest tube care: Nursing
Analgesics for obstetrics: Nursing pharmacology
Analgesics: Nursing pharmacology
Acne: Nursing
Burn injury: Nursing
Impetigo: Nursing
Insect stings and bites: Nursing
Psoriasis: Nursing
Herpes zoster: Nursing
Urticaria: Nursing
Pressure injury: Nursing process (ADPIE)
Cholinergic therapy (GU): Nursing pharmacology
Physical assessment - Skin, hair, and nails: Nursing
Acetylcholinesterase inhibitors for myasthenia gravis: Nursing pharmacology
Antiepileptics: Nursing pharmacology
Narcolepsy (NORD)
Autism spectrum disorder (ASD): Nursing
Insomnia
Hemorrhagic stroke - Intracranial hemorrhage (ICH) and subarachnoid hemorrhage (SAH): Nursing
Body fluid compartments
Anemia - Macrocytic: Nursing
Anemia - Iron-deficiency: Nursing
Vitamin D
Vitamin B12 deficiency
Role of Vitamin K in coagulation
Folate (Vitamin B9) deficiency
Coronary artery disease (CAD) and angina pectoris: Nursing process (ADPIE)
Hypertension: Nursing process (ADPIE)
Hypersensitivity reactions - Type I: Nursing
Hypersensitivity reactions - Type III: Nursing
Hypersensitivity reactions - Type IV: Nursing
Immune response - Adaptive: Nursing
Immune response - Innate: Nursing
Human immunodeficiency virus (HIV) and acquired immunodeficiency syndrome (AIDS): Nursing
Antiglaucoma medications: Nursing pharmacology
Oral antidiabetic medications - Sodium-glucose co-transporter-2 (SGLT-2) inhibitors: Nursing pharmacology
Insulin: Nursing pharmacology
Non-insulin injectable antidiabetic drugs - GLP-1 agonists and amylinomimetics: Nursing pharmacology
Oral antidiabetic medications - Biguanides and thiazolidinediones: Nursing pharmacology
Oral antidiabetic medications - Sulfonylureas and meglitinides: Nursing pharmacology
Oral antidiabetic medications - DPP-4 inhibitors: Nursing pharmacology
Oral antidiabetic medications - Alpha-glucosidase inhibitors: Nursing pharmacology
Antihistamines: Nursing pharmacology
Antacids: Nursing pharmacology
Antiemetics: Nursing pharmacology
Gastric mucosal protective agents: Nursing pharmacology
Antidiarrheals: Nursing pharmacology
Laxatives: Nursing pharmacology
Antispasmodics (GI): Nursing pharmacology
Chronic obstructive pulmonary disease (COPD): Nursing process (ADPIE)
Physiology of pain: Nursing

Notes

SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)

KEY POINTS
NOTES
DEFINITION
  • Chronic autoimmune disease that affects multiple systems, mainly the skin, joints, and serous membranes

PHYSIOLOGY
  • Immune system
    • Protects the body from harmful agents
    • Foreign particle enters body
    • Engulfed by macrophages
    • Presented to T lymphocytes

CAUSES AND RISK FACTORS
  • Cause
    • Unknown
  • Risk factors
    • Multifactorial
    • Genetic susceptibility
    • Altered immune system function
    • Exposure to certain triggers
    • Assigned female at birth
    • Family history of lupus
    • Black, Hispanic, or Asian race

PATHOPHYSIOLOGY
  • Immune system forms auto-antibodies (anti-nuclear antibodies [ANA]) that target nucleic acids, such as DNA or RNA
  • ANA bind to nucleic acids and immune  complexes are formed
  • Precipitate in the walls of blood vessels supplying the brain, heart, skin, kidneys, and joints
  • Triggers type III hypersensitivity reaction
  • Chronic inflammation of the affected blood vessels
  • Complications
    • Skin damage
    • Alopecia
    • Increased risk of  coronary artery disease
    • End-stage renal disease
    • Visual changes
    • Anxiety
    • Depression
    • Gastrointestinal obstruction and inflammatory bowel syndrome
    • Pregnancy loss, preeclampsia, and eclampsia
    • Osteoporosis
    • Increased infection risk

SIGNS AND SYMPTOMS
  • Fever
  • Weight loss
  • Malar rash 
  • Discoid rash
  • Photosensitivity
  • Ulcers in mucous membranes
  • Serositis
  • Inflammation of the myocardium
  • Pain in multiple joints and myalgia
  • Glomerulonephritis, proteinuria, hematuria
  • Seizures, psychosis, personality changes, peripheral neuropathy
  • Dysphagia, nausea and vomiting, abdominal pain, diarrhea
  • Menstrual abnormalities
  • Hematologic disorders

DIAGNOSIS
  • History
  • Physical assessment
  • Laboratory tests
  • ECG
  • Urinalysis
  • X-ray

TREATMENT
  • Depends on severity of symptoms and organ systems affected
  • NSAIDs
  • Steroid-sparing medications
  • Antimalarials
  • Immunosuppressants
  • Anticoagulants

MANAGEMENT OF CARE
  • Goals of care
    • Control symptoms
    • Monitor for organ damage
    • Provide psychosocial support
  • Assess vital signs and neurological status
    • Report to HCP
      • Fever
      • Headache
      • Vision changes
      • Severe joint pain and swelling
  • Administer prescribed medications
  • Place in a comfortable position
  • Non-pharmacological pain management
  • Cluster activities
  • Monitor for organ damage
  • Insert indwelling urinary catheter
  • Monitor intake and output
    • Report to HCP
      • Elevated BP
      • Edema
      • Oliguria
      • Hematuria
      • Proteinuria
      • Cellular casts
      • Elevated BUN and creatinine

PATIENT AND FAMILY TEACHING
  • Explain condition, plan of care, and how to safely administer medications
  • Keep all follow-up appointments
  • Strategies to manage disease and improve quality of life
  • Rest
  • Stress management
  • Sleep
  • Avoid household chemicals and UV light
  • Avoid those who are sick
  • Moderate exercise
  • Dietary modifications
  • Smoking cessation
  • Report to HCP
    • Chest pain or pressure
    • Sudden weakness or light-headedness
    • Shortness of breath
    • Decreased urination
    • Increased fatigue
    • Loss of appetite
    • Hair loss
    • Skin rashes
    • New sores in mouth or nose

Transcript

Watch video only

Systemic lupus erythematosus, or simply SLE or lupus, is a chronic autoimmune disease that affects multiple systems, mainly the skin, joints, and serous membranes.

SLE is progressive, meaning that it gets worse over time with alternating periods of remission and exacerbation. A less common type of lupus particularly affects the skin, called cutaneous lupus erythematosus, or CLE for short. Clients with this condition eventually develop a full-blown SLE over time.

Now, let’s quickly recap the physiology of the immune system, which protects the body from harmful agents. This can be done with the aid of immune cells, including macrophages and lymphocytes.

So, let’s imagine that a foreign particle enters the body, it will be faced by macrophages, which swallow this harmful agent and break it down, leaving a small particle called an antigen. The macrophage then presents this antigen on its surface for another type of immune cells to recognize, called T lymphocytes. Types of T lymphocytes include cytotoxic T lymphocytes, which fight against intracellular pathogens and cancer cells by initiating cell death; as well as T helper cells, which activate another type of lymphocytes, called B lymphocytes.

Once activated, B lymphocytes can differentiate into plasma cells or memory cells. Plasma cells produce antibodies. These bind to antigens found on the surface of the pathogen, producing immune complexes.

So, an antibody tags the pathogen for other immune cells to recognize. In contrast, memory cells monitor the body for the same antigen, and when the pathogen visits the body again, these cells convert to plasma cells, and start producing antibodies to fight this pathogen even faster than the first exposure.

During development, the immune cells learn how to skip the antigens found on the surface of body cells and not react to them, called self-tolerance. This is the main function of another type of T lymphocytes, called regulatory T cells, which suppress the immune system to maintain self-tolerance.

Now, the exact cause of systemic lupus erythematosus is unknown, but it’s thought to be multifactorial, involving genetic susceptibility, altered immune system function, and exposure to certain triggers such as cigarette smoke and ultraviolet light.

Lupus is also more common in individuals assigned female at birth, especially during childbearing years; those with a family history of Lupus; and Black, Hispanic, or Asian individuals.

Alright, now the pathology of systemic lupus erythematosus starts with a genetically susceptible client, meaning that they have less functional regulatory T cells. Add a hormonal or an environmental trigger to that, and self-tolerance is lost. This causes the immune system to form auto-antibodies that target nucleic acids, such as DNA or RNA.

Therefore, these auto-antibodies are called anti-nuclear antibodies, or ANA for short. Now, when these ANAs bind to nucleic acids, immune complexes are formed, and these immune complexes eventually precipitate in the walls of blood vessels supplying the brain, heart, skin, kidneys, and joints. This triggers an abnormal immune response, called type III hypersensitivity reaction, which leads to chronic inflammation of the affected blood vessels and reduced perfusion of the affected organs.

Complications of systemic lupus erythematosus typically arise from the organ damage caused by the disease, or as a side effect of the medications used to treat the disease. These complications include skin damage, alopecia, and increased risk of coronary artery disease, in addition to end-stage renal disease.

Complications can also arise in the nervous system, including visual changes, anxiety, and depression. Complications of the gastrointestinal system include intestinal obstruction and inflammatory bowel syndrome. Complications of the reproductive system include pregnancy loss, preeclampsia, and eclampsia. Finally, clients with lupus that receive long-term steroids can develop complications, such as osteoporosis and increased risk for infections.

In terms of clinical manifestations, there are general ones, like fever and weight loss, as well as specific manifestations depending on the organ system being affected. The skin is often affected, so clients with lupus classically present with a malar rash, or "butterfly rash," over the cheeks that spares the nasolabial folds. Additional skin manifestations include a discoid rash, which is a plaque-like chronic rash in sun-exposed areas, and a general photosensitivity of the skin.

Another type of tissue that can be damaged is the mucosa of various organs, so ulcers in the mucus membrane of the mouth or the nose might be present.

Lupus can also affect the serous, or outer membrane of an organ, so clients can get serositis, which could manifest as pleuritis, or inflammation of the lining around the lungs and chest cavity; as peritonitis, which is inflammation of the lining of the abdomen, or as pericarditis, which is inflammation of the lining of the heart.

In addition to pericarditis, lupus can also cause inflammation of the myocardium, leading to myocarditis, or the endocardium, leading to Libman-Sacks endocarditis, where clumps of fibrin and immune cells form vegetations on the mitral or aortic valve. The musculoskeletal system is also frequently involved, so clients can experience pain in multiple joints, and myalgia.

Next is the urinary system, where lupus can lead to glomerulonephritis, proteinuria, and hematuria. For neurological manifestations, these include seizures, psychosis, personality changes, and peripheral neuropathy.

Gastrointestinal manifestations, such as dysphagia, nausea and vomiting, abdominal pain, and diarrhea, are also common. Some clients may also experience reproductive manifestations like menstrual abnormalities. Finally, components of the blood can be affected , causing various hematologic disorders, anemia, thrombocytopenia, and leukopenia.

The diagnosis of systemic lupus erythematosus starts with the client’s history and physical examination, followed by diagnostic tests. The gold standard test for the diagnosis of lupus is the ANA test, which measures the amount of antinuclear antibodies in the blood. Now a large proportion of clients with lupus have these, meaning this test is very sensitive, but this test isn’t very specific, since these are seen in other autoimmune diseases.

Other autoantibodies can also be detected, including anti-dsDNA, anti-Smith, which are actually relatively specific for lupus, and antiphospholipid antibodies.

Additionally, clients with lupus that has developed as a reaction to certain medications typically have elevated auto-antibodies against histones, which are small proteins around which the DNA loops.

Additional diagnostic tests are sometimes also performed, including a complete blood count, serum complement levels, electrocardiography, urinalysis, as well as chest x-ray, and x-rays of the affected joints.